165-301: A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety and Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN165 Self Administered by Adults with Phenylketonuria Not.......
- Burton, Barbara K (PD/PI)
Project: Research project